Injective (INJ) is currently trading at $8.45, reflecting a 2.09% increase in the past 24 hours. However, trading volume has dipped by 24.03%, standing at $75.11 million. Over the past week, the asset has shown stability at the same price level, suggesting consolidation within a narrow range.

According to technical indicators, INJ continues to navigate a cautious market, balancing modest upward movement with lower liquidity. The asset’s resilience despite declining volume points toward sustained investor confidence amid broader market corrections.
Crypto analyst Profit Demon highlighted that INJ is currently testing the lower support of a descending triangle on the weekly chart. This pattern often indicates potential for a rebound if support holds. A recovery wave, he noted, could drive INJ toward higher resistance zones at $14.50, $28.30, and possibly $50.00, should bullish momentum strengthen.
This forecast aligns with the general sentiment among long-term holders who anticipate a breakout after a prolonged consolidation phase. Technical signals suggest that a decisive close above resistance could trigger renewed buying activity, marking the beginning of a mid-term bullish cycle.

Also Read | Injective (INJ) Faces Bearish Breakdown as Analyst Targets $9
According to DigitalCoinPrice, the token could surpass $18.61 by year-end, potentially revisiting its previous all-time high of $52.75. Experts expect Injective to trade between $17.97 and $18.61, assuming favorable macroeconomic conditions and sustained network adoption.
Similarly, Changelly’s 2025 outlook anticipates a minimum price of $13.95 and a maximum of $15.27, averaging $14.47 throughout the year. Analysts project a potential ROI of 82%, with INJ possibly fluctuating between $8.24 and $14.97 in October 2025.
Also Read | Injective INJ Price Rebounds from $10 Support, Eyes Breakout Above $18 Resistance